出来高 | 3,322,755 |
|
|||||
ニュース | - |
名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
Summit Therapeutics Inc | SMMT | NASDAQ | Depository Receipt |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
7.95 | 7.68 | 8.35 | 8.13 | 8.04 |
取引数 | 出来高 | VWAP | Financial Volume | 平均音量 |
---|---|---|---|---|
24,395 | 3,322,755 | 8.03 | 26,686,462 | - |
最終取引 | タイプ | 数量 | 価格 | 通貨 |
---|---|---|---|---|
08:38:00 | formt | 135 | 8.07 | USD |
Summit Therapeutics (SMMT) のオプションフロー概要
企業情報 - Summit Therapeutics Inc
時価総額 | 発行済株式数 | Float | 歳入 | 利益/損失 | 一株当たり利益 | PER |
---|---|---|---|---|---|---|
5.68B | 700.84M | - | 1M | -614.93M | -0.88 | - |
Short Interest | 1株あたり配当 | 配当利回り | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ニュース - Summit Therapeutics
日付 | 時間 | 情報元 | タイトル |
---|---|---|---|
2024/6/03 | 19:18 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/6/03 | 19:05 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/6/03 | 18:30 | Business Wire | Summit Raises $200 Million; Also Expands License Territories.. |
2024/6/01 | 21:00 | Business Wire | Ivonescimab Manuscript for HARMONi-A Clinical Trial Results.. |
2024/6/01 | 08:00 | Business Wire | Ivonescimab in Combination with Chemotherapy Approved in.. |
2024/5/31 | 07:00 | Business Wire | Summit Therapeutics Reports Inducement Grants Under Nasdaq.. |
2024/5/31 | 05:48 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/31 | 03:29 | Business Wire | Ivonescimab Monotherapy Decisively Beats Pembrolizumab.. |
2024/5/24 | 21:35 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/13 | 21:03 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/5/13 | 20:48 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
2024/5/01 | 20:00 | Business Wire | Summit Therapeutics Reports Financial Results and.. |
チャート - Summit Therapeutics
期間 † | 始値 | 高値 | 安値 | VWAP | 平均出来高 | 前日比 | % |
---|---|---|---|---|---|---|---|
1週 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |